Portfolio company
Brink Biologics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company supplies natural killer cell lines to pharmaceutical and biotechnology firms for laboratory testing and bioanalytical assay applications.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CryoLogyx
CryoLogyx provides cryopreserved, assay-ready cell lines for researchers in the drug discovery, diagnostics and biotechnology sectors.
Partillion Bio
This company produces nanovial reagent kits for single-cell analysis and sorting, serving pharmaceutical, biotechnology and academic research laboratories.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
Bio-Techne Corporation
This company manufactures life science reagents, analytical instruments and precision diagnostics for academic researchers, biopharmaceutical companies and clinical diagnostic laboratories.
BioCeros
This company provides cell line development services for monoclonal antibody production to biotechnology firms, pharmaceutical companies and academic institutions.
ORIG3N
This biotechnology company develops direct-to-consumer genetic testing kits and maintains a biorepository of stem cells to support medical researchers and pharmaceutical firms in drug discovery.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
Oria Bioscience
This company provides isolated biological organelles to pharmaceutical firms and researchers for drug discovery and high-throughput screening applications.
